July 18, 2023
PID Forum Navigating the Complexities of the Pharmaceutical Legislation
On June 7, IPOPI held a very well attended PID Forum entitled “Navigating the complexities of the pharmaceutical legislation” at the European Parliament in Brussels. The event was co-chaired by three Members of the European Parliament: MEP Billy Kelleher (Renew, Ireland); MEP Cyrus Engerer (S&D, Malta) and MEP Tomislav Sokol (EPP, Croatia).
The PID Forum was used to discuss and analyse the proposal for a pharmaceutical legislation from the perspective of patients with primary immunodeficiencies (PIDs) and to be the basis for a Call to Action. The proposal for the pharmaceutical legislation, published by the European Commission, includes measures for the development of medicines for rare diseases, aiming to foster more innovation in the development of medicines and avoid shortages of therapies.
The event, moderated by Ms. Martine Pergent, President of IPOPI, counted with the interventions of:
- Leire Solis, IPOPI health policy and advocacy senior manager, to set the scene.
- Julia Schmitz, from the European Commission, who introduced the proposal to the audience and focused on how patients could benefit from the proposed change in legislation.
- Luisa Antunes, from the European Parliament Directorate-General for Parliamentary Research Services.
- Juan García-Burgos, from the European Medicines Agency.
- Otilia Stanga, ARPID President and IPOPI Treasurer.
The PID Forum also had the participation of patient representatives: David Jimenez (IPOPI’s Spanish member), José Verstegen and Janine Smith (IPOPI’s Dutch member) and Kersti Urbala (IPOPI’s Estonian member).
The report of the event and the Call to Action will shortly be available in IPOPI’s website. Stay tuned!
IPOPI would like to thank CSL Behring, Grifols, Takeda for their continued support.
